The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.


Updates from The Motley Fool

Latest updates on Abiomed from Fool.com.


Stock Performance

ABMD vs. S&P 500 | 2 Year Performance
View Interactive ABMD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Abiomed.
Current Price: $126.72
Prev Close: $123.53
Open: $123.25
Bid: $126.72
Ask: $135.00
Day's Range: $122.26 - $127.22
52wk Range: $67.80 - $127.86
Volume: 429,545
Avg Vol 325,075
Market Cap: $5.38B
P/E (ttm): 124.78
EPS (ttm): $0.99
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Abiomed.
CAPS Rating 4 out of 5
 
164 Outperform
33 Underperform
CAPS All Stars
 
29 Outperform
10 Underperform

How do you think Abiomed will perform against the market?



You pick for Abiomed is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael R. Minogue, CEO

68% Approve

Based on 22 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Abiomed.

The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT